Objective:To review the most used intracorporeal orthotopic ileal neobladder(ICONB)after radical cystectomy for bladder cancer and create a unified compendium of the different alternatives,including new consistent ima...Objective:To review the most used intracorporeal orthotopic ileal neobladder(ICONB)after radical cystectomy for bladder cancer and create a unified compendium of the different alternatives,including new consistent images.Methods:We performed a non-systematic review of the literature with the keywords“bladder cancer”,“urinary diversion”,“radical cystectomy”,and“neobladder”.Results:Forty studies were included in the analysis.The most frequent type of ICONB was the modified Studer“U”neobladder(70%)followed by the Hautmann“W”modified neobladder(7.5%),the“Y”neobladder(5%),and the Padua neobladder(5%).The operative time to perform a urinary diversion ranged from 124 to 553 min.The total estimated blood loss ranged from 200 to 900 mL.The rate of positive surgical margins ranged from 0%to 8.1%.Early minor and major complication rates ranged from 0%to 100%and from 0%to 33%,respectively.Late minor and major complication rates ranged from 0%to 70%and from 0%to 25%,respectively.Conclusion:The most frequent types of ICONB are Studer“U”neobladder,Hautmann“W”neobladder,“Y”neobladder,and the Padua neobladder.Randomized studies comparing the performance of the different types of ICONB,the performance in an intra or extracorporeal manner,or the performance of an ICONB versus ICIC are lacking in the literature.To this day,there are not sufficient quality data to determine the supremacy of one technique.This manuscript represents a compendium of the most used ICONB with detailed descriptions of the technical aspects,operative and perioperative outcomes,and new consistent images of each technique.展开更多
目的:探讨单孔腹腔镜下根治性膀胱切除术联合原位回肠新膀胱术的疗效及安全性。方法:选取2017年01月至2019年12月于本中心收治的17例膀胱癌患者,其中7例患者在经尿道途径的辅助下行单孔腹腔镜根治性膀胱切除术联合原位回肠新膀胱术;另...目的:探讨单孔腹腔镜下根治性膀胱切除术联合原位回肠新膀胱术的疗效及安全性。方法:选取2017年01月至2019年12月于本中心收治的17例膀胱癌患者,其中7例患者在经尿道途径的辅助下行单孔腹腔镜根治性膀胱切除术联合原位回肠新膀胱术;另外10例为对照组,行多孔腹腔镜下根治性膀胱切除术联合原位回肠新膀胱术,并对两组患者围手术期资料、手术并发症以及术后随访情况进行分析。结果:两组共17例膀胱癌患者均顺利完成手术,无中转开放手术。两组患者的年龄、体质量指数(body mass index,BMI)等差异均无统计学意义(P>0.05)。单孔组与对照组平均手术时间分别为(341.4±52.1)min和(333.0±59.5)min,术中平均出血量分别为(206.4±104.6)mL和(190.5±82.3)mL,盆腔淋巴结清扫平均个数分别为17(7~22)个和18(12~23)个,术后平均住院天数分别为(25.1±5.4)d和(26.8±6.0)d,差异均无统计学意义(P>0.05)。而单孔组在术后VAS疼痛评分和切口满意度评分上则优于对照组(P<0.05)。其中单孔组患者术后随访12个月时患者的最大尿流量、最大膀胱容量、最大膀胱充盈量均明显比6个月时高,而随访12个月时患者的残余尿量较6个月时低,差异均具有统计学意义(P<0.05)。结论:经尿道辅助单孔腹腔镜下根治性膀胱切除术联合原位回肠新膀胱术是安全可行的,且术后的新膀胱功能较为良好。展开更多
目的:观察膀胱癌患者行根治性膀胱切除回肠膀胱术、原位回肠代膀胱术术后生活质量。方法:采用癌症患者生活质量核心问卷(EORTC QLQ-C30 Version 3中文版),分别对35例回肠膀胱术和25例原位回肠代膀胱术术后患者生活质量进行调查。结果:...目的:观察膀胱癌患者行根治性膀胱切除回肠膀胱术、原位回肠代膀胱术术后生活质量。方法:采用癌症患者生活质量核心问卷(EORTC QLQ-C30 Version 3中文版),分别对35例回肠膀胱术和25例原位回肠代膀胱术术后患者生活质量进行调查。结果:回肠膀胱术和原位回肠代膀胱术,两种不同术式对膀胱癌术后患者总体生活质量的影响无明显差别(P>0.05),而对膀胱癌术后患者躯体功能、角色功能、情绪功能、社会功能方面的影响存在显著性差异(P<0.05)。结论:在临床医疗工作中应充分考虑到影响患者生活质量的各种因素,根据患者的具体情况,为其提供有效的干预措施,提高患者术后生活质量。展开更多
文摘Objective:To review the most used intracorporeal orthotopic ileal neobladder(ICONB)after radical cystectomy for bladder cancer and create a unified compendium of the different alternatives,including new consistent images.Methods:We performed a non-systematic review of the literature with the keywords“bladder cancer”,“urinary diversion”,“radical cystectomy”,and“neobladder”.Results:Forty studies were included in the analysis.The most frequent type of ICONB was the modified Studer“U”neobladder(70%)followed by the Hautmann“W”modified neobladder(7.5%),the“Y”neobladder(5%),and the Padua neobladder(5%).The operative time to perform a urinary diversion ranged from 124 to 553 min.The total estimated blood loss ranged from 200 to 900 mL.The rate of positive surgical margins ranged from 0%to 8.1%.Early minor and major complication rates ranged from 0%to 100%and from 0%to 33%,respectively.Late minor and major complication rates ranged from 0%to 70%and from 0%to 25%,respectively.Conclusion:The most frequent types of ICONB are Studer“U”neobladder,Hautmann“W”neobladder,“Y”neobladder,and the Padua neobladder.Randomized studies comparing the performance of the different types of ICONB,the performance in an intra or extracorporeal manner,or the performance of an ICONB versus ICIC are lacking in the literature.To this day,there are not sufficient quality data to determine the supremacy of one technique.This manuscript represents a compendium of the most used ICONB with detailed descriptions of the technical aspects,operative and perioperative outcomes,and new consistent images of each technique.
文摘目的:探讨单孔腹腔镜下根治性膀胱切除术联合原位回肠新膀胱术的疗效及安全性。方法:选取2017年01月至2019年12月于本中心收治的17例膀胱癌患者,其中7例患者在经尿道途径的辅助下行单孔腹腔镜根治性膀胱切除术联合原位回肠新膀胱术;另外10例为对照组,行多孔腹腔镜下根治性膀胱切除术联合原位回肠新膀胱术,并对两组患者围手术期资料、手术并发症以及术后随访情况进行分析。结果:两组共17例膀胱癌患者均顺利完成手术,无中转开放手术。两组患者的年龄、体质量指数(body mass index,BMI)等差异均无统计学意义(P>0.05)。单孔组与对照组平均手术时间分别为(341.4±52.1)min和(333.0±59.5)min,术中平均出血量分别为(206.4±104.6)mL和(190.5±82.3)mL,盆腔淋巴结清扫平均个数分别为17(7~22)个和18(12~23)个,术后平均住院天数分别为(25.1±5.4)d和(26.8±6.0)d,差异均无统计学意义(P>0.05)。而单孔组在术后VAS疼痛评分和切口满意度评分上则优于对照组(P<0.05)。其中单孔组患者术后随访12个月时患者的最大尿流量、最大膀胱容量、最大膀胱充盈量均明显比6个月时高,而随访12个月时患者的残余尿量较6个月时低,差异均具有统计学意义(P<0.05)。结论:经尿道辅助单孔腹腔镜下根治性膀胱切除术联合原位回肠新膀胱术是安全可行的,且术后的新膀胱功能较为良好。
文摘目的:观察膀胱癌患者行根治性膀胱切除回肠膀胱术、原位回肠代膀胱术术后生活质量。方法:采用癌症患者生活质量核心问卷(EORTC QLQ-C30 Version 3中文版),分别对35例回肠膀胱术和25例原位回肠代膀胱术术后患者生活质量进行调查。结果:回肠膀胱术和原位回肠代膀胱术,两种不同术式对膀胱癌术后患者总体生活质量的影响无明显差别(P>0.05),而对膀胱癌术后患者躯体功能、角色功能、情绪功能、社会功能方面的影响存在显著性差异(P<0.05)。结论:在临床医疗工作中应充分考虑到影响患者生活质量的各种因素,根据患者的具体情况,为其提供有效的干预措施,提高患者术后生活质量。
